Abstract
It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.
| Original language | English |
|---|---|
| Pages (from-to) | 115-117 |
| Number of pages | 3 |
| Journal | Haematologica |
| Volume | 88 |
| Issue number | 1 |
| Publication status | Published - 2003 Feb 1 |
| Externally published | Yes |
Keywords
- Engraftment
- GVHD
- Mismatched reduced-intensity stem cell transplantation
ASJC Scopus subject areas
- Hematology
Fingerprint Dive into the research topics of 'The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch'. Together they form a unique fingerprint.
Cite this
Nakai, K., Mineishi, S., Kami, M., Konda, Y., Tanosaki, R., & Takaue, Y. (2003). The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch. Haematologica, 88(1), 115-117.